Other Transaction Agreement N000142390001

Award Date 12/16/22
Potential Completion Date 12/15/25
Potential Value $30M
Contracting Federal Agency
Office of Naval Research
Ultimate Awardee
Not listed
NAICS Category
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Manchester, NH 03101, USA
Solicitation Procedures
Broad Agency Announcement
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) awarded a $28.5 million Other Transaction Agreement to Deka Research & Development Corporation of Manchester, New Hampshire. The three-year contract, which runs from December 16, 2022 through December 15, 2025, will provide research and development services to HHS ASPR. Deka Research & Development Corporation will serve as the prime contractor, with subcontracting...
This is a $749,095 firm fixed-price federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response to The Charles Stark Draper Laboratory, Inc. (doing business as Draper), a not-for-profit research and development organization. The contract, which does not have a set-aside designation, is for the development of a "bioinspired microfluidic oxygenator for long duration ECMO without anticoagulation." Draper has extensive experience as both a prime...
This is a federal contract award to Regeneron Pharmaceuticals Inc., a for-profit manufacturer of pharmaceuticals and therapeutics. The $692,086,314.00 award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract is for the development and production of "novel antibodies against influenza virus, emerging, re-emerging, and pre-emerging pathogens" under an Other...
The Department of Health and Human Services' Biomedical Advanced Research and Development Authority awarded a $269,952,453 firm fixed price definitive contract to Global Health Investment Corporation, a nonprofit organization. This contract establishes a public-private partnership through BARDA's other transaction authority to address gaps in pandemic preparedness and response. Specifically, the partnership will foster and accelerate medical countermeasure development using strategic venture...
This is a $5,727,831.00 delivery order awarded to Battelle Memorial Institute, a nonprofit research and development organization, by the Office of the Assistant Secretary for Preparedness and Response within the Department of Health and Human Services. The order is for the repurposing of two chemical compounds, panhematin and disulfiram, as potential medical countermeasures against chemical warfare agents. This work is not subject to a small business set-aside. Battelle has sub-awarded a portion...
This is a $749,000.00 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to HDT Bio Corp. The contract supports Research and Development (R&D) on the use of HDT Bio's Lion-ReRNA technology in rapid response vaccine development, specifically for an Accelerated Capabilities Initiative (AOI) focused on "Vaccine on Demand." The...
This is a $719,000.00 firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response to The Charles Stark Draper Laboratory, Inc. to develop a high-throughput and immune-competent lung-on-chip with integrated sensing for SARS-CoV-2 analysis. The contract is not set aside for any specific business type. Draper is a not-for-profit research and development organization with expertise in areas such as guidance, navigation, control systems, sensors,...
The Defense Health Agency (DHA) awarded a $2,986,772.93 Firm Fixed Price contract to Perfusion Medical LLC, a small business biotechnology company, for IND-enabling studies of PM-208, a novel pre-hospital anti-shock therapeutic. This contract, which is part of the Small Business Innovation Research (SBIR) program Phase II, is set aside for small businesses. Perfusion Medical LLC specializes in developing innovative intravenous solutions for treating acute medical conditions such as septic shock,...
This is a $5,275,114 definitive, cost-plus-fixed-fee contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Keranetics Inc., a for-profit medical research and development company. The contract is for preclinical, regulatory, and manufacturing development activities, with a completion date of May 30, 2026. The contract is not set aside. Keranetics has previously supported HHS and Department of Defense medical...
This federal contract award, HHSF223201610523P, was issued by the Food and Drug Administration (FDA) to Repligen Corporation, a for-profit manufacturer of advanced bioprocessing equipment. The $105,364.76 firm fixed-price purchase order is for the delivery of bioreactor parts and Repligen's ATF (Alternating Tangential Flow) devices, which are critical components used in biopharmaceutical manufacturing processes such as vaccine development. The contract has a Total Small Business set-aside...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) awarded Deka Research & Development Corp, a for-profit subchapter S corporation based in Manchester, New Hampshire, a $30,100,000 Other Transaction Agreement to develop an "IV Fluid Therapy Modular Manufacturing System." This contract, which does not have a set-aside designation, aims to bolster national preparedness for public health emergencies by ensuring access to critical medical supplies. Deka Research & Development Corp has previously received a $28,500,000 Other Transaction Agreement from HHS ASPR for broad research and development services. Additionally, the company has served as a subcontractor on a federal award to develop anti-viral coating materials and processes for masks.

Generated 11/19/24, 9:18 AM